Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Embecta Corp. - Common Stock (NQ: EMBC )

11.71 +0.47 (+4.23%)
Streaming Delayed Price Updated: 12:30 PM EDT, Apr 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 65,018
Open 11.35
Bid (Size) 11.70 (5)
Ask (Size) 11.73 (4)
Prev. Close 11.24
Today's Range 11.25 - 11.72
52wk Range 10.00 - 21.48
Shares Outstanding N/A
Dividend Yield 5.12%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Becton Dickinson Q1 Earnings: Revenue And EPS Beat, Lowers Outlook, Outlines Intent To Separate Biosciences And Diagnostic Solutions Business
Becton Dickinson plans to spin off its Biosciences and Diagnostic Solutions unit, targeting a fiscal 2026 completion, while updating FY25 revenue guidance. 
Via Benzinga
Embecta Corp. Reports First Quarter Fiscal 2025 Financial Results
From Embecta Corp.
Via GlobeNewswire

Performance

YTD
-42.15%
-42.15%
1 Month
-8.90%
-8.90%
3 Month
-37.49%
-37.49%
6 Month
-16.44%
-16.44%
1 Year
+7.67%
+7.67%

More News

Read More
embecta Announces Quarterly Cash Dividend
From Embecta Corp.
Via GlobeNewswire
Earnings Scheduled For February 6, 2025
Via Benzinga
Activist Starboard Value Pushes Becton Dickinson To Divest Life Sciences Unit
Via Benzinga
Uncovering Potential: Embecta's Earnings Preview
Via Benzinga
embecta to Report Fiscal First Quarter 2025 Financial Results
From Embecta Corp.
Via GlobeNewswire
Aehr Test Systems Posts Weak Results, Joins Trump Media & Technology Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Topics Government
Exposures Political
embecta to Participate at the 43rd Annual J.P. Morgan Healthcare Conference
From Embecta Corp.
Via GlobeNewswire
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Via Benzinga
This Dick's Sporting Goods Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Crude Oil Moves Lower; Dick's Sporting Goods Earnings Top Views
Via Benzinga
Exposures Fossil Fuels
Becton Dickinson Spinoff Embecta Stops Insulin Patch Pump Program, Plans Restructuring, Stock Jumps
Via Benzinga
Nasdaq Rises 100 Points; Abercrombie & Fitch Shares Fall After Q3 Results
Via Benzinga
J.M. Smucker Posts Upbeat Earnings, Joins LexinFintech, Semtech, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Embecta Corp. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2025 Financial Guidance; Discontinues Insulin Patch Pump Program; and Announces Restructuring to Streamline Operations and Reduce Costs
From Embecta Corp.
Via GlobeNewswire
embecta Announces Quarterly Cash Dividend
From Embecta Corp.
Via GlobeNewswire
Earnings Scheduled For November 26, 2024
Via Benzinga
UPDATE - embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results
From Embecta Corp.
Via GlobeNewswire
embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results
From Embecta Corp.
Via GlobeNewswire
embecta Celebrates National Diabetes Awareness Month by Ringing Nasdaq Closing Bell
From Embecta Corp.
Via GlobeNewswire
embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes
From Embecta Corp.
Via GlobeNewswire
embecta to Participate in Investor Events
From Embecta Corp.
Via GlobeNewswire
EMBC Stock Earnings: Embecta Beats EPS, Beats Revenue for Q3 2024
Via InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.